Incidence of Hemorrhagic Complications among Patients Treated with Thrombolytic in Erbil City, Iraq

Background: Recombinant tissue-type plasminogen activator is an option of treatment for suspected occlusive vascular thrombi and its sequel (transmural myocardial infarction, pulmonary embolism, and ischemic stroke). The most important concern associated with those patients is the fear of hemorrhagi...

Full description

Bibliographic Details
Main Authors: Ahmed F. Hammad, Imad T. Abdulhafed, Abdulsalam R. Awad
Format: Article
Language:English
Published: University of Anbar 2020-12-01
Series:Al-Anbar Medical Journal
Subjects:
Online Access:https://amj.uoanbar.edu.iq/article_170955_c923e8b479beeee0aa8720460d617813.pdf